MedTrace Logo

Inflammatory and Immune Response After High Intensity Exercise

NCT05277727 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2022-07-12

No results posted yet for this study

Summary

This double-blinded, randomized, placebo-controlled, cross-over study is designed to evaluate the potential effects of a fucoidan supplement on the inflammatory and immune responses following high intensity exercise.

Conditions

  • Inflammatory Response

Interventions

DIETARY_SUPPLEMENT

Fucoidan 500mg

1 capsule to be taken twice daily with food (morning and evening).

DIETARY_SUPPLEMENT

Placebo

1 capsule to be taken twice daily with food (morning and evening).

Sponsors & Collaborators

  • Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

    collaborator NETWORK

  • University of South Carolina

    collaborator OTHER

  • Marinova Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Bridget McFadden · Principal Investigator

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-05
Primary Completion
2022-03-04
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05277727 on ClinicalTrials.gov